The generation of transgenic pigs as potential organ donors for humans

Nature Medicine

Volumn 1, Issue 9, 1995, Pages 964-966

  Cozzi, Emanuele ^a   White, David J G ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SHORT SURVEY; SWINE; TRANSGENIC ANIMAL;

ANIMAL; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; ANTIGENS, CD59; CARBOHYDRATE SEQUENCE; COMPLEMENT 3 CONVERTASE; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EPITOPES; FORECASTING; GRAFT REJECTION; HUMAN; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SWINE; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029068597     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0995-964     Document Type: Article

References (30)

1. Cooper, D.K.C., Ye, Y., Rolf, J.L.L. and Zuhdi, N. The pig as potential organ donor for man in Xenotransplantation: The Transplantation of Organs and Tissues Between Species (eds Cooper, D.K.C., Kemp, E., Reemtsma, K. and White, D.J.G.) 481-500 (Springer, Berlin, 1991).
2. Caine, R.Y. Organ transplantation between widely disparate species. Transplantn Proc, 2, 550-553 (1970).
3. Sachs, D.H. and Bach, F.H. Immunology of xenograft rejection. Hum. Immun. 28, 245-251 (1990).
4. Dalmasso, A.P. et al. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol 140, 1157-1166 (1992).
5. Johnston, P.S., Wang, M.W., Lim, S.M., Wright, L.J. and White, D.J, Discordant xenograft rejection in an antibody-free model. Transplantation 54, 573-576 (1992).
6. Platt, J.L. et al Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 52, 214-220 (1991).
7. Kemp, E., Kemp, G., Starklint, H. and Larsen, S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplantn Proc. 14, 116 (1982).
8. Braidley, P.C., Dunning, J.J., Wallwork, J. and White, D.J.G. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Transplantn Proc. 26, 1259-1260 (1994).
9. Leventhal, J.R. et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857-865 (1993).
10. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363-370 (1994).
11. Lachmann, P.J. The control of homologous lysis. Imrnun. Today. 12, 312-315 (1991).
12. Atkinson, J.P., Odlesby, T.J., White, D.J.G., Adams, E.A. and Liszewski, M.K. Separation of self from non self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. exp. Immun. 86, 27-30 (1991).
13. Oglesby, T.J., Allen, C.J., Liszewski, M.K., White, D.J. and Atkinson, J.P. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. exp. Med. 175, 1547-1551 (1992).
14. White, D.J.G. et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant. Int. 5, 648-650 (1992).
15. Dalmasso, A.P., Vercelloti, G.M., Platt, J.L. and Bach, F.H. Inhibition of complement mediated cytotoxicity by decay accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530-533 (1991).
16. Cary, N., Moody, J., Yannoutsos, N., Wallwork, J. and White, D. Tissue expression of human decay accelerating factor, a regulator of com-plement activation expressed in mice: A potential approach to inhibition of hyperacute xenograft rejection. Transplantn Proc. 25, 400-401 (1993).
17. Diamond, L. et al. Cell and tissue specific expression of a human CD59 minigene in transgenic mice. Transplantn Proc. 26, 1239 (1994).
18. Rosengard, A.M. et al. Tissue expression of human complement inhibitor, decay- accelerating factor, in transgenic pigs — a potential approach for preventing xenograft rejection. Transplantation 59, 1325-1333 (1995).
19. Fodor, W.L. et al. Expression of a functional human complement inhibitor in transgenic swine as an approach to prevent xenogeneic hy-peracute organ rejection. Proc. natn. Acad. Sci. U.S.A. 91, 11153-11157 (1994).
20. Miyagawa, S. et al. Effect of transfectant molecules, MCP, DAF, and MCPJDAF hybrid on xenogeneic vascular endothelium. Transplantn Proc. 26, 1253-1254 (1994).
21. Walsh, L.A., Tone, M. and Waldmann, H. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Eur. J. Immun. 21, 847-850 (1991).
22. Charreau, B. et al. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 andJor decay- accelerating factor. Transplantation 58, 1222-1229 (1994).
23. Van den Berg, C.W. and Morgan, B.P. Complement- inhibiting activities of human CD59 and analogues from rat, sheep and. pig are not homologously restricted. J. Immun. 152, 4095-4101 (1995).
24. Langford, G.A. et al. Production of pigs transgenic for human decay accelerating factor. Transplantn Proc. 26, 1400-1401 (1994).
25. White, D.J.G., Langford, G.A., Cozzi, E. and Young, V. J. Protective effects of human DAF in transgenic pigs. Xeno (in the press).
26. McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423-427, (1995).
27. Bach, F.H. et al. Discordant xenografting: A working model of problems and issues. Xeno 1, 8-15 (1993).
28. Cooper, D.K.C., Koren, E. and Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol Rev. 141, 31-58 (1994).
29. Sandrin, M.S., Vaughan, H.A. and McKenzie, I.F.C. Identification of Gala(l-3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplantn Rev. 8, 134-149 (1994).
30. Yannoutsos, N. et al. Production of pigs transgenic for human regulators of complement activation. Transplantn Proc. 27, 324-325 (1995).